Related Experiment Videos
Reading ability and central visual field after photodynamic therapy
Ilse Krebs1, Susanne Binder, Ulrike Stolba
1Department of Ophthalmology, Rudolf Foundation Clinic, The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Surgery, Vienna, Austria. Ilse.Krebs@wienkav.at
Summary
Photodynamic therapy (PDT) effectively prevents severe vision loss in age-related macular degeneration patients. Most patients maintained or improved reading and distance acuity, with significant visual field preservation.
Area of Science:
- Ophthalmology
- Medical therapy
Background:
- Age-related macular degeneration (AMD) can cause severe vision loss.
- Subfoveal neovascularization is a major cause of AMD-related visual impairment.
Purpose of the Study:
- To evaluate the efficacy of photodynamic therapy (PDT) in preventing vision loss.
- To assess PDT's impact on reading acuity and visual fields in AMD.
Main Methods:
- Biomicroscopy, visual acuity, and visual field testing were performed.
- Fluorescein angiography was used for diagnosis and monitoring.
- Sixty eyes of 52 patients with AMD received PDT.
Main Results:
- After 18 months, 53.3% gained reading acuity, with 18.7% improving by over 3 levels.
- 81.7% lost less than 3 lines of distance acuity, and 78.3% showed no central visual field deterioration.
Conclusions:
- PDT is effective in preventing severe vision loss in approximately 80% of eyes with AMD.
- While PDT can prevent further decline, it may not restore already lost reading acuity.